Investors & Dealmaking
Healthcare Data is Driving Medtech Strategy: What Dealmakers Need to Know
Access to data and the use of it are increasingly important components of corporate strategy. How it is valued, structured and owned differentiates companies and raises challenges in dealmaking. A panel organized this month by Medtech Strategist for Weill Cornell Medicine’s BioVenture eLab Accelerator sought clarity, and an innovative, focused venture capitalist separately gives her firm’s creative investment thesis.
